Log in
Log in


Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

31 Dec 2022 8:21 PM | Michele O'Bright (Administrator)

Evan S. Dellon, M.D., M.P.H., Marc E. Rothenberg, M.D., Ph.D., Margaret H. Collins, M.D., Ikuo Hirano, M.D., Mirna Chehade, M.D., M.P.H., Albert J. Bredenoord, M.D., Ph.D., Alfredo J. Lucendo, M.D., Ph.D., Jonathan M. Spergel, M.D., Ph.D., Seema Aceves, M.D., Xian Sun, Ph.D., Matthew P. Kosloski, Ph.D., Mohamed A. Kamal, Pharm.D., Ph.D., et al.

Read Abstract:  Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

Affiliated Societies

International  Interdisciplinary  Everything Esophageal

The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries:
Membership Questions:

Powered by Wild Apricot Membership Software